Familial Hypercholesterolemia Biomarker Distribution in Dried Blood Spots

Patrice K Held1, Michael Lasarev2, Xiao Zhang3

  • 1Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR; Oregon State Public Health Laboratory, Oregon Health Authority, Hillsboro, OR.

Insights

Low-density lipoprotein cholesterol (LDL-C) and apolipoprotein B (apoB) show promise for newborn screening of familial hypercholesterolemia. These biomarkers, unlike total cholesterol (TC), exhibit distributions suitable for identifying at-risk infants.

Area of Science:

  • Neonatal screening
  • Biomarker analysis
  • Cardiovascular health

Background:

  • Familial hypercholesterolemia (FH) is a genetic disorder leading to high cholesterol levels.
  • Early detection of FH in newborns is crucial for preventing cardiovascular disease.
  • Current newborn screening methods for FH are limited.

Purpose of the Study:

  • To assess the distribution profiles of total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and apolipoprotein B (apoB) in newborns.
  • To evaluate these biomarkers as potential indicators for neonatal familial hypercholesterolemia screening.
  • To consider confounding factors like gestational age, birth weight, sex, and race.

Main Methods:

  • Analysis of 10,000 deidentified newborn dried blood spot cards.
  • Measurement of TC, LDL-C, and apoB concentrations.
  • Reporting concentrations as multiples of the median, focusing on 99th percentile values stratified by birth weight, gestational age, sex, and race.
  • Exploration of seasonal biomarker variations.

Main Results:

  • LDL-C and apoB distributions showed extreme elevations, indicating potential for screening.
  • TC distribution was less elevated with a smaller range.
  • Early gestational age and low birth weight were associated with higher 99th percentile apoB levels.
  • Sex and race had minimal impact on biomarker concentrations.
  • Biomarker levels were highest in winter compared to summer.

Conclusions:

  • LDL-C and apoB exhibit distribution characteristics supportive of their use in neonatal FH screening.
  • Further research is required to validate these biomarkers through correlation with molecular testing and later childhood cholesterol levels.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
205
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
611
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
127
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
208